Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 Including: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs. Covering: Novartis AG, Sanofi S.A., Pfizer Inc. and Gilead Sciences Inc.
Region:Global
Product Code:o&s005
July 2018
430
About the Report
The global pharmaceutical drug market was worth USD 934.8 billion in 2017 and has grown at a CAGR of 5.16% during 2013-2017. The market is expected to grow at a CAGR of 5.78% during 2017-2021 and is forecast to be worth USD 1,170.4 billion by 2021. Global GDP is expected to grow significantly to 2021, so the 5.78% annual growth of the global pharma market does not register in the percentage figures. Aging populations, income growth especially in emerging economies and the high prices of new drugs are factors leading to steadily increasing per capita drugs expenditure.
North America accounted for 36.5% of the global pharmaceutical drugs market in 2017 and was worth USD 341.1 billion. This market share was primarily due to the better healthcare system, access to high value drugs, healthcare awareness, high per capita expenditure on healthcare and high GDP of the region. Asia Pacific was the second largest region with a share of 21.8% in 2017 and the market was worth USD 200.8 billion. This was mainly due to the prevalence of chronic conditions and the large population based of the region. Western Europe was the third largest region accounting for USD 180.9 billion or 19.4% of the market. This market was driven by increased investment in research and development, aging population, ability to afford high value drugs and established healthcare system. South America was the fourth largest region accounting for USD 80.9 billion or 8.6% of the market. Rising disposable income, government healthcare policies and availability of affordable generic drugs are main drivers of this market. Eastern Europe was fifth largest region accounting for USD 60.9 billion or 6.5% of the market followed by Middle East with a share of 4.4%, USD 41.3 billion, and Africa with a market worth USD 28.8 billion in 2017.
At the country level, The USA was the largest country in the pharmaceutical drugs market in 2017, accounting for USD 234.7 billion or 25.1% market. The USA's per capita medical drugs spend has been and will be to 2021 the world's highest, followed by those of Australia and Germany. China was the second largest country accounting for USD 52.6 billion followed by Japan with a market worth USD 43 billion in 2017. Germany was the fourth largest country accounting for USD 37 billion in 2017. Russia was the smallest country accounting for USD 12.1 billion and this can be attributed to the presence of generics and less reliance on imported pharmaceutical drugs.
As a percentage of GDP in 2013 the USA's drugs expenditure was highest, but by 2017 it had been overtaken by both Brazil and Italy, whose market was worth USD 29.1 billion and USD 24.7 billion respectively, and the situation will continue to 2021. In terms of the number of pharmacist, the huge populations of India and China meant that these countries had the highest number of pharmacists in 2017. Three of the BRICs, India, China and Brazil, have low spend on pharma, despite very high numbers of pharmacists, implying that the drugs revenue per pharmacist in these countries is relatively low. With more generic drugs occupying the market, it was observed that 70% of drug sales in India were generics whereas in many Western countries it was much lower, for example in Italy generics made up only 11% of the market. New drug approvals in 2017 were highest in Brazil, 61, and lowest in the USA, followed by Europe. In part this pattern is explained by countries approving drugs approved in the USA in earlier years and the slow and difficult process for new drug approvals in the USA and Europe.
At the global level, pharmaceutical drugs are segmented based on the therapeutic area with drugs for musculoskeletal disorders as the largest segment worth USD 130.2 billion in 2017. Cardiovascular drugs were the second largest segment followed by oncology drugs with a market worth USD 129.6 billion and 125.9 billion respectively. Ophthalmology Drugs was the smallest major segment in the pharmaceutical drugs market worth about USD 27.7 billion.
Scope of the Report
Products
Companies
North America: Pfizer Inc., Amgen, AbbVie, Abbott Laboratories, F. Hoffmann-La Roche, Gilead Science, Johnson & Johnson, Merck & Co., Eli Lilly and Company, Astellas Pharma, Q Pharm, 3M Pharmaceuticals
Asia-Pacific: Shanghai Pharmaceuticals, Shanghai Fosun Pharmaceutical, Cipla, Dr. Reddy's Laboratories Ltd., Sun Pharma, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo
Western Europe: Bayer, Roche, Novartis, Sanofi, GlaxoSmithKline, Teva Pharmaceutical Industries, AstraZeneca, Boehringer Ingelheim, Novo Nordisk
South America: EMS Pharma, Hypermarcas, Medley, Sanofi, Novartis, Ache, Eurofarma, Takeda, Bayer, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Libbs, Uniao Quimica, Roche, Merck, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline
Eatern Europe: Pharmstandard, STADA CIS Russian Holding, Sotex, Microgen, AKRIKHIN, Sanofi, Aventis, Novartis, Roche, Bayer, Pfizer, GlaxoSmithKline
Middle East: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Gulf Pharmaceutical Industries (Julphar), Pfizer, Merck, GSK, Abbott Laboratories
Africa: Sanofi, Novartis, Cipla, Pfizer, Roche, Bayer, Adcock Ingram, Johnson & Johnson, Aspen
Table of Contents
1. Executive Summary
2. Pharmaceutical Drugs Market Characteristics
2.1. Global Pharmaceutical Drugs Market Size And Growth
2.2. Global Pharmaceutical Drugs Historic Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
2.3. Global Pharmaceutical Drugs Market Forecast Growth
2.3.1. Drivers Of The Market
2.3.2. Restraints On The Market
4. Global Pharmaceutical Drugs Market, PESTLE Analysis
4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental
5. Pharmaceutical Drugs Market Customer Information
6. Pharmaceutical Drugs Market Regional And Country Analysis
6.1. Pharmaceutical Drugs Market, 2017, Split By Region
6.2. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region
6.3. Pharmaceutical Drugs Market, 2017, Split By Country
6.4. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Country
7. Global Pharmaceutical Drugs Market Segmentation
7.1. Global Pharmaceutical Drugs Market, Split By Segments, 2017, USD Billion
7.1.1. Musculoskeletal Disorders Drugs
7.1.2. Cardiovascular Drugs
7.1.3. Oncology Drugs
7.1.4. Anti-infective Drugs
7.1.5. Metabolic Disorder Drugs
7.1.6. Central Nervous System Drugs
7.1.7. Genito-urinary Drugs
7.1.8. Respiratory Drugs
7.1.9. Gastrointestinal Drugs
7.1.10. Hematology Drugs
7.1.11. Dermatology Drugs
7.1.12. Ophthalmology Drugs
7.2. Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segments
8. Pharmaceutical Drugs Market Segments And Subsegments
8.1. Musculoskeletal Disorders Drugs
8.1.1. Musculoskeletal Disorders Drugs Market Characteristics
8.1.2. Musculoskeletal Disorders Drugs Market Trends & Strategies
8.1.3. Global Musculoskeletal Disorders Drugs Market, By Subsegment
8.1.3.1. Drugs for Rheumatoid Arthritis
8.1.3.2. Muscle Relaxants
8.1.3.3. Others
8.1.4. Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.1.5. Global Musculoskeletal Drugs Market Competitive Landscape
8.1.6. Global Musculoskeletal Drugs Market Key Mergers And Acquisitions
8.2. Cardiovascular Drugs
8.2.1. Cardiovascular Drugs Market Characteristics
8.2.2. Cardiovascular Drugs Market Trends & Strategies
8.2.3. Global Cardiovascular Drugs Market, Segmentation By Subsegment
8.2.3.1. Anti-hypertensive Drugs
8.2.3.2. Hypolipidemics
8.2.3.3. Anti Thrombotics
8.2.3.4. Other Drugs For Cardiovascular Diseases
8.2.4. Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.2.5. Global Cardiovascular Drugs Market Competitive Landscape
8.2.6. Global Cardiovascular Drugs Market Key Mergers And Acquisitions
8.3. Oncology Drugs
8.3.1. Oncology Drugs Market Characteristics
8.3.2. Oncology Drugs Market Trends & Strategies
8.3.3. Global Oncology Drugs Market, Segmentation By Subsegment
8.3.3.1. Blood Cancer
8.3.3.2. Breast Cancer
8.3.3.3. Cervical Cancer
8.3.3.4. Lung Cancer
8.3.3.5. Colorectal Cancer
8.3.3.6. Non-Small Cell Lung Cancer
8.3.3.7. Prostate Cancer
8.3.3.8. Kidney Cancer
8.3.3.9. Gastric Cancer
8.3.3.10. Brain Tumor
8.3.3.11. Pancreatic Cancer
8.3.3.12. Skin Cancer
8.3.3.13. Ovarian Cancer
8.3.3.14. Bladder Cancer
8.3.3.15. Thyroid Cancer
8.3.3.16. Others
8.3.4. Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.3.5. Global Oncology Drugs Market Competitive Landscape
8.3.6. Global Oncology Drugs Market Key Mergers And Acquisitions
8.4. Anti-Infective Drugs
8.4.1. Anti-infective Drugs Market Characteristics
8.4.2. Anti-infective Drugs Market Trends & Strategies
8.4.3. Global Anti-Infective Drugs Market, Segmentation By Subsegment
8.4.3.1. Antivirals
8.4.3.2. Antibiotics
8.4.3.3. Antifungals
8.4.3.4. Antiparasitic
8.4.4. Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rates, By Subsegment
8.4.5. Global Anti-Infective Drugs Market Competitive Landscape
8.4.6. Global Anti-Infective Drug Market Key Mergers and Acquisitions
8.5. Metabolic Disorders Drugs
8.5.1. Metabolic Disorders Drugs Market Characteristics
8.5.2. Metabolic Disorders Drugs Market Trends & Strategies
8.5.3. Global Metabolic Disorders Drugs Market, Segmentation By Subsegment
8.5.3.1. Anti-diabetics Drugs
8.5.3.2. Anti-thyroid drugs
8.5.3.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
8.5.4. Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.5.5. Global Metabolic Disorder Drugs Market Competitive Landscape
8.5.6. Global Metabolic Disorders Drugs Market Key Mergers And Acquisitions
8.6. Central Nervous System Drugs
8.6.1. Central Nervous System Drugs Market Characteristics
8.6.2. Central Nervous System Drugs Market Trends & Strategies
8.6.3. Global Central Nervous System Drugs Market, Segmentation By Subsegment
8.6.3.1. Anesthetics
8.6.3.2. Analgesics
8.6.3.3. Anti-Parkinson drugs
8.6.3.4. Anti-Epileptics
8.6.3.5. Other CNS drugs
8.6.4. Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.6.5. Global Central Nervous System Market Competitive Landscape
8.6.6. Global Central Nervous System Drugs Market Key Mergers And Acquisitions
8.7. Genito-Urinary Drugs
8.7.1. Genito-Urinary Drugs Market Characteristics
8.7.2. Genito-Urinary Drugs Market Trends & Strategies
8.7.3. Global Genito-Urinary Drugs Market, Segmentation By Subsegment
8.7.3.1. Hormonal Contraceptives
8.7.3.2. Drugs For Hormonal Replacement Therapy
8.7.3.3. Drugs For Infections And Others
8.7.3.4. Drugs for Benign prostatic hypertrophy
8.7.3.5. Drugs For Erectile Dysfunction
8.7.3.6. Drugs For Urinary Incontinence And Overactive Bladder
8.7.3.7. Drugs for Infertility
8.7.3.8. Diuretics
8.7.4. Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment
8.7.5. Global Genito-Urinary Drugs Market Competitive Landscape
8.7.6. Genito-urinary Drugs Market Key Mergers And Acquisitions
8.8. Respiratory Diseases
8.8.1. Respiratory Diseases Drugs Market Characteristics
8.8.2. Respiratory Diseases Drugs Market Trends & Strategies
8.8.3. Global Respiratory Diseases Market, Segmentation By Subsegment
8.8.3.1. Anti-Asthmatics And COPD Drugs
8.8.3.2. Cough And Cold Preparations
8.8.4. Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.8.5. Global Respiratory Diseases Drugs Market Competitive Landscape
8.8.6. Global Respiratory Drugs Market Key Mergers And Acquisitions
8.9. Gastrointestinal Drugs
8.9.1. Gastrointestinal Drugs Market Characteristics
8.9.2. Gastrointestinal Drugs Market Trends & Strategies
8.9.3. Global Gastrointestinal Drugs Market, Segmentation By Subsegment
8.9.3.1. Antiulcerants
8.9.3.2. Vitamins And Minerals
8.9.3.3. Antacids
8.9.3.4. Antiemetics And Antinauseants
8.9.3.5. Antiobesity
8.9.3.6. Antidiarrhoeals
8.9.4. Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.9.5. Global Gastrointestinal Drugs Market Competitive Landscape
8.9.6. Global Gastrointestinal Drugs Market Key Mergers And Acquisitions
8.1. Hematology Drugs
8.10.1. Hematology Drugs Market Characteristics
8.10.2. Hematology Drugs Market Trends & Strategies
8.10.3. Global Hematology Drugs Market, Segmentation By Subsegment
8.10.3.1. Blood Products
8.10.3.2. Anemia And Other Blood Disorder Drugs
8.10.4. Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.10.5. Global Hematology Drugs Market Competitive Landscape
8.10.6. Global Hematology Drugs Market Key Mergers And Acquisitions
8.11. Dermatology Drugs
8.11.1. Dermatology Drugs Market Characteristics
8.11.2. Dermatology Drugs Market Trends & Strategies
8.11.3. Global Dermatology Drugs Market Competitive Landscape
8.11.4. Dermatology Drugs Market Key Mergers And Acquisitions
8.12. Ophthalmology Drugs
8.12.1. Ophthalmology Drugs Market Characteristics
8.12.2. Ophthalmology Drugs Market Trends & Strategies
8.12.3. Global Ophthalmology Drugs Market, Segmentation By Subsegment
8.12.3.1. Antiglaucoma
8.12.3.2. Dry Eye Medication
8.12.3.3. Other Opthalmological Drugs
8.12.4. Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.12.5. Global Ophthalmology Drugs Market Competitive Landscape
8.12.6. Ophthalmology Drugs Market Key Mergers And Acquisitions
9. Pharmaceutical Drugs Market Comparison With Macro Economic Factors
9.1. Pharmaceutical Drugs Market Size And Percentage Of GDP, Global
9.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
9.3. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
9.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
9.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
10. Pharmaceutical Drugs Market Comparison With Industry Metrics
10.1. Number Of General Practitioners 2017, By Country
10.2. Average Pharmaceutical Drugs Revenue Per General Practitioner, 2017, By Country
10.3. Number Of Pharmacists, 2017, By Country
10.4. Average Pharmaceutical Drugs Revenue Per Pharmacist, 2017, By Country
10.5. Number Of Employees In Pharmaceutical Industry, 2017, By Country
10.6. Average Revenue Per Pharmaceutical Employee, 2017, By Country
10.7. Number Of Pharmaceutical Enterprises, 2017, By Country
10.8. Average Pharmaceutical Drugs Revenue Per Pharmaceutical Enterprise, 2017, By Country
10.9. Number Of Pharmacies Per 100,000 Population, 2017, By Country
10.1. Generic & Branded Sales Proportion By Country (Value), 2016, By Country
10.11. New Drug Approvals, 2017, By Country
11. Asia-Pacific Pharmaceutical Drugs Market
11.1. Asia-Pacific Pharmaceutical Drugs Market Overview
11.2. Asia Pacific Pharmaceutical Market
11.3. Asia Pacific Pharmaceutical Drugs Historic Market Growth
11.4. Asia Pacific Pharmaceutical Drugs Market Forecast Growth
11.5. Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type
11.6. Asia Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis
12.1. China Pharmaceutical Drugs Market
12.1.1. China Pharmaceutical Drugs Market Overview
12.1.2. China Pharmaceutical Market
12.1.3. China Pharmaceutical Drugs Historic Market Growth
12.1.4. China Pharmaceutical Drugs Market Forecast Growth
12.1.5. China Pharmaceutical Drugs Market, Segmentation By Type
12.1.6. China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12.2. India Pharmaceutical Drugs Market
12.2.1. India Pharmaceutical Drugs Market Overview
12.2.2. India Pharmaceutical Market
12.2.3. India Pharmaceutical Drugs Historic Market Growth
12.2.4. India Pharmaceutical Drugs Market Forecast Growth
12.2.5. India Pharmaceutical Drugs Market, Segmentation By Type
12.2.6. India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12.3. Japan Pharmaceutical Drugs Market
12.3.1. Japan Pharmaceutical Drugs Market Overview
12.3.2. Japan Pharmaceutical Market
12.3.3. Japan Pharmaceutical Drugs Historic Market Growth
12.3.4. Japan Pharmaceutical Drugs Market Forecast Growth
12.3.5. Japan Pharmaceutical Drugs Market, Segmentation By Type
12.3.6. Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12.3. Australia Pharmaceutical Drugs Market
12.3.1. Australia Pharmaceutical Market
12.3.2. Australia Pharmaceutical Drugs Historic Market Growth
12.3.3. Australia Pharmaceutical Drugs Market Forecast Growth
12.3.4. Australia Pharmaceutical Drugs Market, Segmentation By Type
12.3.5. Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
13. Western Europe Pharmaceutical Drugs Market
13.1. Western Europe Pharmaceutical Drugs Market Overview
13.2. Western Europe Pharmaceutical Market
13.3. Western Europe Pharmaceutical Drugs Historic Market Growth
13.4. Western Europe Pharmaceutical Drugs Market Forecast Growth
13.5. Western Europe Pharmaceutical Drugs Market, Segmentation By Type
13.6. Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14. Western Europe Pharmaceutical Drugs Market: Country Analysis
14.1. UK Pharmaceutical Drugs Market
14.1.1. UK Pharmaceutical Drugs Market Overview
14.1.2. UK Pharmaceutical Market
14.1.3. UK Pharmaceutical Drugs Historic Market Growth
14.1.4. UK Pharmaceutical Drugs Market Forecast Growth
14.1.5. UK Pharmaceutical Drugs Market, Segmentation By Type
14.1.6. UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.2. Germany Pharmaceutical Drugs Market
14.2.1. Germany Pharmaceutical Market
14.2.2. Germany Pharmaceutical Drugs Historic Market Growth
14.2.3. Germany Pharmaceutical Drugs Market Forecast Growth
14.2.4. Germany Pharmaceutical Drugs Market, Segmentation By Type
14.2.5. Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.3. France Pharmaceutical Drugs Market
14.3.1. France Pharmaceutical Market
14.3.2. France Pharmaceutical Drugs Market Historic Growth
14.3.3. France Pharmaceutical Drugs Market Forecast Growth
14.3.4. France Pharmaceutical Drugs Market, Segmentation By Type
14.3.5. France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.4. Italy Pharmaceutical Drugs Market
14.4.1. Italy Pharmaceutical Market
14.4.2. Italy Pharmaceutical Drugs Historic Market Growth
14.4.3. Italy Pharmaceutical Drugs Market Forecast Growth
14.4.4. Italy Pharmaceutical Drugs Market, Segmentation By Type
14.4.5. Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.5. Spain Pharmaceutical Drugs Market
14.5.1. Spain Pharmaceutical Market
14.5.2. Spain Pharmaceutical Drugs Historic Market Growth
14.5.3. Spain Pharmaceutical Drugs Market Forecast Growth
14.5.4. Spain Pharmaceutical Drugs Market, Segmentation By Type
14.5.5. Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
15. Eastern Europe Pharmaceutical Drugs Market
15.1. Eastern Europe Pharmaceutical Drugs Market Overview
15.2. Eastern Europe Pharmaceutical Market
15.3. Eastern Europe Pharmaceutical Drugs Historic Market Growth
15.4. Eastern Europe Pharmaceutical Drugs Market Forecast Growth
15.5. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type
15.6. Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rate, Segmentation By Type
15.7. Eastern Europe Pharmaceutical Drugs Market: Country Analysis
15.7.1. Russia Pharmaceutical Drugs Market
15.7.2. Russia Pharmaceutical Drugs Historic Market Growth
15.7.3. Russia Pharmaceutical Drugs Market Forecast Growth
15.7.4. Russia Pharmaceutical Drugs Market, Segmentation By Type
15.7.5. Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
16. North America Pharmaceutical Drugs Market
16.1. North America Pharmaceutical Drugs Market Overview
16.2. North America Pharmaceutical Market
16.3. North America Pharmaceutical Drugs Historic Market Growth
16.4. North America Pharmaceutical Drugs Market Forecast Growth
16.5. North America Pharmaceutical Drugs Market, Segmentation By Type
16.6. North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
16.7. North America Pharmaceutical Drugs Market: Country Analysis
16.7.1. USA Pharmaceutical Drugs Market Overview
16.7.2. USA Pharmaceutical Market
16.7.3. USA Pharmaceutical Drugs Historic Market Growth
16.7.4. USA Pharmaceutical Drugs Market Forecast Growth
16.7.5. USA Pharmaceutical Drugs Market, Segmentation By Type
16.7.6. USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
17. South America Pharmaceutical Drugs Market
17.1. South America Pharmaceutical Drugs Market Overview
17.2. South America Pharmaceutical Market
17.3. South America Pharmaceutical Drugs Historic Market Growth
17.4. South America Pharmaceutical Drugs Market Forecast Growth
17.5. South America Pharmaceutical Drugs Market, Segmentation By Type
17.6. South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
17.7. South America Pharmaceutical Drugs Market: Country Analysis
17.7.1. Brazil Pharmaceutical Drugs Market
17.7.2. Brazil Pharmaceutical Market
17.7.3. Brazil Pharmaceutical Drugs Historic Market Growth
17.7.4. Brazil Pharmaceutical Drugs Market Forecast Growth
17.7.5. Brazil Pharmaceutical Drugs Market, Segmentation By Type
17.7.6. Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
18. Middle East Pharmaceutical Drugs Market
18.1. Middle East Pharmaceutical Drugs Market Overview
18.2. Middle East Pharmaceutical Market
18.3. Middle East Pharmaceutical Drugs Historic Market Growth
18.4. Middle East Pharmaceutical Drugs Market Forecast Growth
18.5. Middle East Pharmaceutical Drugs Market, Segmentation By Type
18.6. Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
19. Africa Pharmaceutical Drugs Market
19.1. Africa Pharmaceutical Drugs Market Overview
19.2. Africa Pharmaceutical Market
19.3. Africa Pharmaceutical Drugs Historic Market Growth
19.4. Africa Pharmaceutical Drugs Market Forecast Growth
19.5. Africa Pharmaceutical Drugs Market, Segmentation By Type
19.6. Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
20. Global Pharmaceutical Drugs Market Competitive Landscape
20.1. Novartis AG
20.1.1. Company Overview
20.1.2. Products And Services
20.1.3. Strategy
20.1.4. Novartis AG Financial Performance
20.2. Sanofi
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Strategy
20.2.4. Sanofi S.A Financial Performance
20.3. Pfizer Inc.
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Strategy
20.3.4. Pfizer Inc. Financial Performance
20.4. Gilead Sciences Inc.
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Strategy
20.4.4. Gilead Sciences Inc. Financial Performance
21. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
22. Pharmaceutical Drugs Market Trends And Strategies
23. Market Background: Healthcare Market
23.1. Healthcare Market Characteristics
23.2. Global Healthcare Historic Market Growth
23.2.1. Drivers Of The Market
23.2.2. Restraints On The Market
23.3. Global Healthcare Forecast Market Growth
23.3.1. Drivers Of The Market
23.3.2. Restraints On The Market
23.4. Healthcare Market Geography Regional And Country Analysis
23.4.1. Healthcare Market, 2017, By Region
23.4.2. Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Region
23.4.3. Healthcare Market, 2017, By Country
23.4.4. Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Country
23.5. Healthcare Market Segmentation, By Region, 2017
23.6. Healthcare Market Segmentation, By Country, 2017
23.7. Global Healthcare Market Comparison With Macro Economic Factors
23.7.1. Global Healthcare Market Size, Percentage Of GDP
23.7.2. Global Per Capita Average Healthcare Expenditure
23.7.3. Healthcare Market Comparison With Macro Economic Factors Across Countries
23.7.3.1. Healthcare Market Size, Percentage Of GDP, By Country
23.7.3.2. Per Capita Average Healthcare Expenditure, By Country
23.8. Key Mergers And Acquisitions In The Healthcare Market
23.9. Healthcare Market Trends And Strategies
30. Appendix
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.